Meltem Alper
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Meltem Alper has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Feray Köçkar
Department of Molecular Biology and Genetics, Faculty of Sciences and Arts, Balıkesir University, Balıkesir, Turkey
9 shared publications - Feyza Nur Sav
Balikesir University, Türkiye
6 shared publications - Yasemin Keleş
Balikesir University, Türkiye
5 shared publications - Ayşe Tuğşen AYDEMİR
Cell Therapy Department Moffitt Cancer Center and Research Institute Tampa Florida USA
3 shared publications - Candan Altuntaş
Department of Stem Cell, Institute of Health Sciences, Kocaeli University, 41001 Kocaeli, Türkiye
2 shared publications - Kübra Paspal Eroğlu
Faculty of Science and Literature, Department of Molecular Biology and Genetics, Balikesir University, Balikesir, Turkey
2 shared publications
Latest Publications
- 19 September 2026
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (12) , 10498-10527
Sodium Sulfite as an Oxygen-Depletion-Based Chemical Model of Tumor Hypoxia In Vitro
- 19 September 2026
- Published by Springer Nature in Applied Biochemistry and Biotechnology
- Vol. 198 (12) , 10498-10527
Sodium Sulfite as an Oxygen-Depletion-Based Chemical Model of Tumor Hypoxia In Vitro
- 29 May 2026
- Published by Elsevier in Tissue and Cell
- Vol. 103, 103636
Hypoxia reprograms VEGF signaling to differentially control ADAMTS2 and ADAMTS3 expression in endothelial cells
- 29 May 2026
- Published by Elsevier in Tissue and Cell
- Vol. 103, 103636
Hypoxia reprograms VEGF signaling to differentially control ADAMTS2 and ADAMTS3 expression in endothelial cells
- Open Access
- 3 May 2026
- Published by Wiley in Journal of Cell Communication and Signaling
- Vol. 20 (2)
Integrative genomic and functional characterization of ADAMTS3 reveals its inflammatory regulation via NF‐κB and STAT3 pathways in osteosarcoma
Osteosarcoma (OS) is an aggressive bone malignancy characterized by genomic instability and extensive extracellular matrix (ECM) remodeling. Members of the ADAMTS family are matrix‐associated proteases implicated in tumorigenesis; however, their roles in OS remain poorly defined. This study provides a comprehensive genomic, transcriptomic, and functional analysis of the ADAMTSs in OS, with particular focus on ADAMTS‐3. Copy number alterations and mRNA expressions of ADAMTS genes were analyzed using the TCGA datasets. Gene set enrichment analysis and co‐expression analyses identified biological processes associated with ADAMTS‐3. Mechanistic studies investigated tumor necrosis factor‐alpha (TNF‐α) regulation of ADAMTS‐3 in OS cells. Genomic profiling revealed frequent amplification and high mRNA expression of ADAMTS4, ADAMTS12, ADAMTS16, and ADAMTS17, indicating potential oncogenic activity. ADAMTS‐3 was markedly overexpressed in OS tissues and cell lines, showing strong positive correlations with inflammatory (IL6, STAT3, NF‐κB) and matrix‐remodeling (MMP2, MMP9) genes. Functional enrichment indicated that ADAMTS‐3 is associated with ECM organization, immune response regulation, and epithelial‐mesenchymal transition. Mechanistically, TNF‐α induced ADAMTS‐3 transcription via activation of MEK, PI3K, JNK, and NF‐κB pathways, with STAT3 and NF‐κB by enhancing promoter activity. These findings identify ADAMTS‐3 as an inflammation‐responsive gene that links inflammatory signaling to ECM remodeling and tumor invasiveness in OS, representing a potential molecular bridge.
- 3 May 2026
- Published by Wiley in Journal of Cell Communication and Signaling
- Vol. 20 (2)
Open AccessIntegrative genomic and functional characterization of ADAMTS3 reveals its inflammatory regulation via NF‐κB and STAT3 pathways in osteosarcoma
Osteosarcoma (OS) is an aggressive bone malignancy characterized by genomic instability and extensive extracellular matrix (ECM) remodeling. Members of the ADAMTS family are matrix‐associated proteases implicated in tumorigenesis; however, their roles in OS remain poorly defined. This study provides a comprehensive genomic, transcriptomic, and functional analysis of the ADAMTSs in OS, with particular focus on ADAMTS‐3. Copy number alterations and mRNA expressions of ADAMTS genes were analyzed using the TCGA datasets. Gene set enrichment analysis and co‐expression analyses identified biological processes associated with ADAMTS‐3. Mechanistic studies investigated tumor necrosis factor‐alpha (TNF‐α) regulation of ADAMTS‐3 in OS cells. Genomic profiling revealed frequent amplification and high mRNA expression of ADAMTS4, ADAMTS12, ADAMTS16, and ADAMTS17, indicating potential oncogenic activity. ADAMTS‐3 was markedly overexpressed in OS tissues and cell lines, showing strong positive correlations with inflammatory (IL6, STAT3, NF‐κB) and matrix‐remodeling (MMP2, MMP9) genes. Functional enrichment indicated that ADAMTS‐3 is associated with ECM organization, immune response regulation, and epithelial‐mesenchymal transition. Mechanistically, TNF‐α induced ADAMTS‐3 transcription via activation of MEK, PI3K, JNK, and NF‐κB pathways, with STAT3 and NF‐κB by enhancing promoter activity. These findings identify ADAMTS‐3 as an inflammation‐responsive gene that links inflammatory signaling to ECM remodeling and tumor invasiveness in OS, representing a potential molecular bridge.
- 6 January 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1869 (1) , 195134
SP1 as a negative regulator of ADAMTS-8 in colorectal cancer: Evidence from functional and molecular analyses
- 6 January 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1869 (1) , 195134
SP1 as a negative regulator of ADAMTS-8 in colorectal cancer: Evidence from functional and molecular analyses
- 3 October 2025
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 84 (1) , 927-942
TNF-α-Induced Upregulation of ADAMTS-8 Expression in SW480 Cells: Implications for Intracellular Signaling Pathways and Transcription Factor Activity
- 3 October 2025
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 84 (1) , 927-942
TNF-α-Induced Upregulation of ADAMTS-8 Expression in SW480 Cells: Implications for Intracellular Signaling Pathways and Transcription Factor Activity
- 19 February 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-12
STAT-3, ELK-1, and c- Jun contributes IL-6 mediated ADAMTS-8 upregulation in colorectal cancer
Background ADAMTSs are extracellular matrix metalloproteinases that mainly process extracellular matrix components and closely related tumorigenesis. ADAMTS-8 is an anti-angiogenic member of the family and is dysregulated in common cancers. The tumor suppressor function of the ADAMTS-8 has been demonstrated in colorectal cancer. Although ADAMTS-8 plays a critical role in tumor progression, transcriptional regulatory features haven’t been studied yet. Materials and methods The human ADAMTS-8 promoter was cloned into the pMetLuc Reporter vector. Basal promoter activity and the effect of the IL-6 on ADAMTS-8 promoter activity were determined by transient transfection assays in SW480 cells. QRT-PCR and Western blot analyses assessed the impact of IL-6 on ADAMTS-8 mRNA and protein expressions. Functional binding of the specific transcription factors to the ADAMTS-8 promoter region was evaluated by ChIP qPCR and EMSA. Results Our results demonstrated that the ADAMTS-8 promoter includes multiple binding sites for transcription factors that could be activated in the inflammatory pathways. IL-6 stimulation increased ADAMTS-8 promoter activity, also mRNA, and protein expressions. Pathway inhibition studies showed that IL-6-mediated induction of ADAMTS-8 was achieved through p38/MAPK, NF-κB, PI3K, and SAPK/JNK pathways. STATs, Elk-1, and c-Jun functionally bind to the ADAMTS-8 promoter region. Conclusion It can be concluded that inflammation is a strong positive regulator of the ADAMTS-8 gene.
- 19 February 2025
- Published by Springer Nature in Molecular Biology Reports
- Vol. 52 (1) , 1-12
STAT-3, ELK-1, and c- Jun contributes IL-6 mediated ADAMTS-8 upregulation in colorectal cancer
Background ADAMTSs are extracellular matrix metalloproteinases that mainly process extracellular matrix components and closely related tumorigenesis. ADAMTS-8 is an anti-angiogenic member of the family and is dysregulated in common cancers. The tumor suppressor function of the ADAMTS-8 has been demonstrated in colorectal cancer. Although ADAMTS-8 plays a critical role in tumor progression, transcriptional regulatory features haven’t been studied yet. Materials and methods The human ADAMTS-8 promoter was cloned into the pMetLuc Reporter vector. Basal promoter activity and the effect of the IL-6 on ADAMTS-8 promoter activity were determined by transient transfection assays in SW480 cells. QRT-PCR and Western blot analyses assessed the impact of IL-6 on ADAMTS-8 mRNA and protein expressions. Functional binding of the specific transcription factors to the ADAMTS-8 promoter region was evaluated by ChIP qPCR and EMSA. Results Our results demonstrated that the ADAMTS-8 promoter includes multiple binding sites for transcription factors that could be activated in the inflammatory pathways. IL-6 stimulation increased ADAMTS-8 promoter activity, also mRNA, and protein expressions. Pathway inhibition studies showed that IL-6-mediated induction of ADAMTS-8 was achieved through p38/MAPK, NF-κB, PI3K, and SAPK/JNK pathways. STATs, Elk-1, and c-Jun functionally bind to the ADAMTS-8 promoter region. Conclusion It can be concluded that inflammation is a strong positive regulator of the ADAMTS-8 gene.
- 30 September 2024
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 8 (3) , 726-733
Effect of Collagen-Coating Variations on the Morphology and Viability of Human Vascular Smooth Muscle Cells
Purpose: Collagen is a critical extracellular matrix (ECM) component that significantly influences cellular behaviors such as adhesion, migration, and proliferation. Optimizing collagen coating protocols is essential for developing accurate in vitro models, particularly for studying vascular smooth muscle cells (HVSMCs). The aim of this study was to optimize collagen coating protocols for in vitro models using HVSMCs by assessing cell morphology, adhesion potential, and viability under various collagen concentrations and incubation conditions. Methods: HVSMCs were cultured on surfaces coated with different concentrations of Type 1 Rat Tail Collagen with different cell number (as 104 cells/well and 204 cells/well). The cells were incubated at various temperatures (4°C, 25°C, and 37°C). Morphological analysis was performed using phase-contrast microscopy to observe the alignment and phenotype of the cells. Cell adhesion was assessed using DAPI staining, and cell viability was evaluated using the Presto Blue assay after 96 hours of incubation. Results: Collagen coating significantly influenced HVSMC behavior. The cells transitioned to a contractile phenotype, evidenced by tight, parallel bundle alignment, which is critical for maintaining vascular tone. Enhanced cell adhesion was observed in specific collagen-coated groups across different temperatures, particularly in the F, G, and H groups. Additionally, collagen coating did not significantly increase cell proliferation, making it suitable for in vitro vascular models. Optimal results were observed in groups seeded with 104 cells and incubated at 25°C and 37°C. Conclusion: The study highlights the importance of optimizing extracellular matrix components like collagen in developing functional in vitro models. The identified optimal conditions for collagen coating will be valuable for future vascular modeling studies, providing a reliable foundation for in vitro research.
- 30 September 2024
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 8 (3) , 726-733
Effect of Collagen-Coating Variations on the Morphology and Viability of Human Vascular Smooth Muscle Cells
Purpose: Collagen is a critical extracellular matrix (ECM) component that significantly influences cellular behaviors such as adhesion, migration, and proliferation. Optimizing collagen coating protocols is essential for developing accurate in vitro models, particularly for studying vascular smooth muscle cells (HVSMCs). The aim of this study was to optimize collagen coating protocols for in vitro models using HVSMCs by assessing cell morphology, adhesion potential, and viability under various collagen concentrations and incubation conditions. Methods: HVSMCs were cultured on surfaces coated with different concentrations of Type 1 Rat Tail Collagen with different cell number (as 104 cells/well and 204 cells/well). The cells were incubated at various temperatures (4°C, 25°C, and 37°C). Morphological analysis was performed using phase-contrast microscopy to observe the alignment and phenotype of the cells. Cell adhesion was assessed using DAPI staining, and cell viability was evaluated using the Presto Blue assay after 96 hours of incubation. Results: Collagen coating significantly influenced HVSMC behavior. The cells transitioned to a contractile phenotype, evidenced by tight, parallel bundle alignment, which is critical for maintaining vascular tone. Enhanced cell adhesion was observed in specific collagen-coated groups across different temperatures, particularly in the F, G, and H groups. Additionally, collagen coating did not significantly increase cell proliferation, making it suitable for in vitro vascular models. Optimal results were observed in groups seeded with 104 cells and incubated at 25°C and 37°C. Conclusion: The study highlights the importance of optimizing extracellular matrix components like collagen in developing functional in vitro models. The identified optimal conditions for collagen coating will be valuable for future vascular modeling studies, providing a reliable foundation for in vitro research.
- 8 July 2024
- Published by Adiyaman University in Adıyaman University Journal of Science
C/EBPα Mediated Transcriptional Regulation of Human ADAMTS-3 Gene and Collagen Expression in Osteosarcoma Cells
ADAMTS-3 is a procollagen amino proteinase mainly expressed in type II collagen-rich tissues and its primary function is to maturate amino ends of the type II collagen precursors. This maturation process allows correct fibril formation. ADAMTS-3 also has a tumor-suppressive function by regulating the fibronectin expression in the ECM. C/EBPα is a transcription factor playing a pivotal role in the cell cycle regulation. Dysregulations in the C/EBPα expression have been reported in solid tumors. C/EBPα expression has been identified to be associated with the metabolism and prognosis of a malignant bone tumor, osteosarcoma (OS). High heterogeneity, metastasis capability, and recurrence lead to poor prognosis and survival rates in OS. Multiple genetic and epigenetic factors affect OS development. Alterations in the ECM elements are closely related to OS development and progression. According to the in-silico analyses, the ADAMTS-3 promoter includes multiple C/EBPα binding sites suggesting that C/EBPα could have a regulatory effect on ADAMTS-3 transcriptional regulation. In the present study, over-expression of the C/EBPα decreased ADAMTS-3 mRNA and protein levels in Saos-2 and MG-63 osteosarcoma models. Ectopic expression of the C/EBPα also led to alterations in some fibrillar collagen expression levels. Enhanced C/EBPα levels resulted in an increase in the type I and II collagen expression levels but didn’t change the type III collagen expression level in Saos-2 cells.
- 8 July 2024
- Published by Adiyaman University in Adıyaman University Journal of Science
C/EBPα Mediated Transcriptional Regulation of Human ADAMTS-3 Gene and Collagen Expression in Osteosarcoma Cells
ADAMTS-3 is a procollagen amino proteinase mainly expressed in type II collagen-rich tissues and its primary function is to maturate amino ends of the type II collagen precursors. This maturation process allows correct fibril formation. ADAMTS-3 also has a tumor-suppressive function by regulating the fibronectin expression in the ECM. C/EBPα is a transcription factor playing a pivotal role in the cell cycle regulation. Dysregulations in the C/EBPα expression have been reported in solid tumors. C/EBPα expression has been identified to be associated with the metabolism and prognosis of a malignant bone tumor, osteosarcoma (OS). High heterogeneity, metastasis capability, and recurrence lead to poor prognosis and survival rates in OS. Multiple genetic and epigenetic factors affect OS development. Alterations in the ECM elements are closely related to OS development and progression. According to the in-silico analyses, the ADAMTS-3 promoter includes multiple C/EBPα binding sites suggesting that C/EBPα could have a regulatory effect on ADAMTS-3 transcriptional regulation. In the present study, over-expression of the C/EBPα decreased ADAMTS-3 mRNA and protein levels in Saos-2 and MG-63 osteosarcoma models. Ectopic expression of the C/EBPα also led to alterations in some fibrillar collagen expression levels. Enhanced C/EBPα levels resulted in an increase in the type I and II collagen expression levels but didn’t change the type III collagen expression level in Saos-2 cells.
- 18 June 2023
- Published by Allerton Press in Cytology and Genetics
- Vol. 57 (3) , 282-289
TGF-β1 Transactivates ADAMTS-2 (ADAM Metallopeptidase with Thrombospondin Type 1 Motif 2) in Saos-2 Cells through Canonical and Non-Canonical Pathways
Osteosarcoma is a malignant bone tumor that is common in children and adolescents. The tumor microenvironment is highly effective in the development and pr
- 18 June 2023
- Published by Allerton Press in Cytology and Genetics
- Vol. 57 (3) , 282-289
TGF-β1 Transactivates ADAMTS-2 (ADAM Metallopeptidase with Thrombospondin Type 1 Motif 2) in Saos-2 Cells through Canonical and Non-Canonical Pathways
Osteosarcoma is a malignant bone tumor that is common in children and adolescents. The tumor microenvironment is highly effective in the development and pr
- 14 October 2022
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 478 (5) , 1151-1160
Hypoxic regulation of ADAMTS-2 and -3 (a disintegrin and matrix metalloproteinase with thrombospondin motifs 2 and 3) procollagen N proteinases by HIF-1α in endothelial cells
ADAMTS-2 and ADAMTS-3, known as procollagen amino proteases (PNP), are primarily responsible for processing the amino ends of the fibrillar collagen precursors. ADAMTS-2 is a highly expressed gene in type I collagen-rich tissues, such as skin, bones, tendons, and aorta. ADAMTS-3 is mainly expressed in cartilage, where it colocalizes with type II procollagen and in the nervous system. Studies about ADAMTS-2 and ADAMTS-3 enzymes primarily focused on their collagen processing activity. Knowledge about the transcriptional regulations of these genes is rather limited. Here we analyzed the transcriptional regulations of ADAMTS-2 and ADAMTS-3 genes under chemically induced hypoxic conditions in endothelial cell model, HUVECs. We elucidated that hypoxia is the potent positive regulator of ADAMTS-2 and ADAMTS-3 genes. qRT-PCR and western blotting studies revealed that ADAMTS-2 and ADAMTS-3 expressions were increased at mRNA and protein levels under chemically induced hypoxic conditions in HUVECs. In addition, Transient transfection experiments of ADAMTS-2 and ADAMTS-3 promoter–reporter constructs indicated that low oxygen conditions increased ADAMTS-2 and ADAMTS-3 promoter activities. Furthermore, the DNA–protein interaction assay provided evidence of the functional binding of HIF-1α on bioinformatically determined HRE regions on the ADAMTS-2 and ADAMTS-3 promoters.
- 14 October 2022
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 478 (5) , 1151-1160
Hypoxic regulation of ADAMTS-2 and -3 (a disintegrin and matrix metalloproteinase with thrombospondin motifs 2 and 3) procollagen N proteinases by HIF-1α in endothelial cells
ADAMTS-2 and ADAMTS-3, known as procollagen amino proteases (PNP), are primarily responsible for processing the amino ends of the fibrillar collagen precursors. ADAMTS-2 is a highly expressed gene in type I collagen-rich tissues, such as skin, bones, tendons, and aorta. ADAMTS-3 is mainly expressed in cartilage, where it colocalizes with type II procollagen and in the nervous system. Studies about ADAMTS-2 and ADAMTS-3 enzymes primarily focused on their collagen processing activity. Knowledge about the transcriptional regulations of these genes is rather limited. Here we analyzed the transcriptional regulations of ADAMTS-2 and ADAMTS-3 genes under chemically induced hypoxic conditions in endothelial cell model, HUVECs. We elucidated that hypoxia is the potent positive regulator of ADAMTS-2 and ADAMTS-3 genes. qRT-PCR and western blotting studies revealed that ADAMTS-2 and ADAMTS-3 expressions were increased at mRNA and protein levels under chemically induced hypoxic conditions in HUVECs. In addition, Transient transfection experiments of ADAMTS-2 and ADAMTS-3 promoter–reporter constructs indicated that low oxygen conditions increased ADAMTS-2 and ADAMTS-3 promoter activities. Furthermore, the DNA–protein interaction assay provided evidence of the functional binding of HIF-1α on bioinformatically determined HRE regions on the ADAMTS-2 and ADAMTS-3 promoters.